NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-18
DOI
10.3389/fimmu.2020.598444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
- (2020) Steven P. Treon et al. BLOOD
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome
- (2020) Jared Radbel et al. CHEST
- Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
- (2020) Shengyu Zhang et al. CLINICAL DRUG INVESTIGATION
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
- (2020) Zhaohai Zheng et al. JOURNAL OF INFECTION
- Elevated Interleukin‐6 and Severe COVID‐19: A Meta‐Analysis
- (2020) Muhammad Aziz et al. JOURNAL OF MEDICAL VIROLOGY
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Immunomodulation in COVID-19
- (2020) Nicholas E Ingraham et al. Lancet Respiratory Medicine
- HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
- (2020) Francesca Romana Spinelli et al. Science Immunology
- Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
- (2020) Bradley J. Langford et al. CLINICAL MICROBIOLOGY AND INFECTION
- Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
- (2020) Vanessa Bianconi et al. DRUGS
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Sex differential in COVID-19 mortality varies markedly by age
- (2020) Sunil S Bhopal et al. LANCET
- COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis
- (2020) Robert Lorenz Chua et al. NATURE BIOTECHNOLOGY
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
- (2020) Leora R. Feldstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multisystem Inflammatory Syndrome in Children in New York State
- (2020) Elizabeth M. Dufort et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- An Insight into the Sex Differences in COVID-19 Patients: What are the Possible Causes?
- (2020) Parisa Maleki Dana et al. Prehospital and Disaster Medicine
- Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
- (2020) Mark Roschewski et al. Science Immunology
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
- (2020) Ligong Lu et al. Frontiers in Cell and Developmental Biology
- Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19
- (2020) Jonathan H. Chow et al. ANESTHESIA AND ANALGESIA
- SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response
- (2020) Jessie Huang et al. Cell Stem Cell
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- (2020) Takehiro Takahashi et al. NATURE
- Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection
- (2020) Michael J. Carter et al. NATURE MEDICINE
- Cytokines in Inflammatory Disease
- (2019) Shinwan Kany et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bruton's tyrosine kinase regulates TLR7/8-induced TNF transcription via nuclear factor-κB recruitment
- (2018) Theresa H. Page et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients
- (2018) Gerhard Scheuch et al. Emerging Microbes & Infections
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- The intricate interplay between RNA viruses and NF-κB
- (2014) M. Lienhard Schmitz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases
- (2012) Selvarajan Chitra et al. International Journal of Rheumatic Diseases
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses
- (2011) Emanuel Haasbach et al. ANTIVIRAL RESEARCH
- Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
- (2010) Saskia L. Smits et al. PLoS Pathogens
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
- (2009) Rogelio Perez-Padilla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteasome inhibition by peptide-semicarbazones
- (2008) Johann Leban et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Role of Hypercytokinemia in NF- B p50-Deficient Mice after H5N1 Influenza A Virus Infection
- (2008) K. Droebner et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More